USP Standards for Compounding Pharmacies: 795, 797 & 800 Explained

Understanding the Quality Standards That Protect Patient Safety

United States Pharmacopeia (USP) standards represent the pharmaceutical industry’s quality benchmark. For compounding pharmacies, three specific chapters—USP 795, 797, and 800—define the requirements that separate legitimate pharmaceutical operations from dangerous amateur compounding. Understanding these standards helps healthcare providers evaluate compounding partners and patients verify they’re receiving safe, effective medications.

The difference between compliance and non-compliance isn’t academic—it’s literally life-or-death. The 2012 fungal meningitis outbreak that killed 64 people resulted from failures in sterile compounding standards. Today, these USP chapters codify the practices that prevent such tragedies.

This comprehensive guide demystifies USP 795, 797, and 800, explaining what each requires, why it matters, and how Newtropin’s partnership with Formulation Compounding Center demonstrates complete compliance across all three standards.

---

Understanding USP (United States Pharmacopeia)

What is USP?

Not a Government Agency:

• Independent, scientific nonprofit organization
• Founded 1820 (over 200 years of pharmaceutical standards)
• Sets quality standards for medicines, supplements, food ingredients
• Globally recognized authority
• No regulatory enforcement power (but standards referenced in law)

Mission:

• Ensure quality, safety, benefit of medications
• Establish standards followed worldwide
• Protect patient health through pharmaceutical standards
• Scientific, evidence-based approach
• Continuously updated based on research and technology

USP Compounding Chapters

Three Critical Standards:

• USP Chapter 795: Non-sterile compounding
• USP Chapter 797: Sterile compounding
• USP Chapter 800: Hazardous drug handling

Legal Weight:

• State Boards of Pharmacy reference USP in regulations
• Failure to comply = violation of state pharmacy law
• FDA inspections assess USP compliance
• Federal Food, Drug, and Cosmetic Act references USP
• Legally binding through state and federal incorporation

Why These Standards Exist

Patient Safety:

• Contaminated medications can kill
• Improper compounding causes treatment failures
• Inconsistent potency creates under/over-dosing
• Poor practices lead to infections, adverse reactions
• Standards codify safe practices

Historical Lessons:

• Multiple compounding-related tragedies over decades
• 2012 fungal meningitis outbreak most catastrophic
• Each incident led to strengthened requirements
• Current standards reflect lessons learned in blood

Professional Accountability:

• Demonstrates commitment to quality
• Protects pharmacy license
• Builds prescriber and patient trust
• Industry best practice
• Competitive advantage for compliant pharmacies

---

USP Chapter 795: Non-Sterile Compounding Standards

Scope: What USP 795 Covers

Applies to ALL Non-Sterile Compounded Preparations:

• Oral medications (capsules, tablets, suspensions, solutions)
• Topical preparations (creams, ointments, gels, lotions, pastes)
• Rectal and vaginal suppositories
• Sublingual troches and lozenges
• Nasal sprays (non-sterile)
• Any compounded medication not requiring sterility

Does NOT Apply to:

• Sterile preparations (covered by USP 797)
• Hazardous drug handling (covered by USP 800)
• Radiopharmaceuticals (separate chapter)

Facility and Equipment Requirements

Compounding Area Standards:

Designated Space:

• Separate area dedicated to compounding (not just counter space)
• Adequate size for equipment and operations
• Organized, clutter-free environment
• Separated from patient counseling/waiting areas
• Clean, well-lit, professional

Environmental Controls:

• Appropriate temperature (20-25°C typical)
• Controlled humidity (30-60% relative humidity)
• Adequate ventilation (air changes appropriate for activities)
• Dust control (HEPA filtration when appropriate)
• Sink with hot and cold water (hand washing)

Surface Materials:

• Smooth, impermeable, easily cleanable
• No cracks, crevices, or porous materials
• Resistant to chemicals and disinfectants
• Maintained in good repair
• Regular cleaning and disinfection

Equipment Required:

Balances:

• Appropriate sensitivity for quantities compounded
• Class III or better (typically 0.001g sensitivity minimum)
• Calibrated regularly (at least annually, more often if heavy use)
• Documented calibration records
• Verified accuracy with known weights

Mixing Equipment:

• Mortars and pestles (glass, porcelain, wedgwood)
• Spatulas (metal, rubber, plastic as appropriate)
• Ointment slabs (glass or disposable)
• Mechanical mixers (for creams, ointments)
• Homogenizers (when needed)
• All cleaned, maintained, appropriate for use

Measuring Devices:

• Graduated cylinders (various sizes)
• Pipettes (volumetric, graduated)
• Syringes (for small volumes)
• Appropriate accuracy for quantities measured
• Clean, calibrated when applicable

Storage:

• Refrigerators and freezers (with temperature monitoring)
• Cabinets for ingredient storage
• Proper segregation (actives vs. inactives)
• Light-protective storage when needed
• Humidity-controlled when required

Personnel Requirements

Training and Competency:

Initial Training:

• Understanding of USP 795 requirements
• Compounding techniques (measuring, mixing, incorporating)
• Equipment operation and maintenance
• Quality control procedures
• Documentation practices
• Safety and hygiene

Competency Assessment:

• Demonstration of proper techniques
• Written or practical evaluation
• Understanding of processes
• Documentation of competency
• Initial and ongoing assessment

Continuing Education:

• Regular updates on standards and techniques
• Changes to USP requirements
• New formulations or methods
• Industry best practices
• Annual training recommended

Personal Hygiene:

• Hand washing before and during compounding
• Clean garments (lab coats)
• Hair restrained
• No eating, drinking, or smoking in compounding area
• Proper personal protective equipment (gloves, safety glasses when appropriate)

Ingredient Quality and Sourcing

Component Standards:

Active Pharmaceutical Ingredients (APIs):

• USP-grade or pharmaceutical-grade only
• FDA-registered supplier required
• Certificate of Analysis (COA) with each lot
• Identity, purity, potency verified
• Expiration dates tracked
• Proper storage conditions maintained

Inactive Ingredients (Excipients):

• USP-grade, National Formulary (NF), or Food Chemical Codex (FCC)
• Quality appropriate for pharmaceutical use
• Documentation of source and quality
• Certificates of Analysis when available
• No cosmetic-grade or food-grade substitutions

Red Flags (Never Acceptable):

• ❌ “Research chemicals” (not pharmaceutical-grade)
• ❌ Unknown or overseas suppliers (no FDA registration)
• ❌ No Certificates of Analysis
• ❌ Expired materials
• ❌ Damaged or improperly stored ingredients
• ❌ Cosmetic or industrial-grade materials

Formulation Compounding Center’s Standards:

• 100% pharmaceutical-grade ingredients
• Only FDA-registered suppliers used
• Complete COAs for every lot
• Documented chain of custody
• Proper storage (temperature, humidity, light protection)
• Expiration tracking systems
• No shortcuts ever

Master Formulation Records and Compounding Records

Master Formulation Record (The “Recipe”):

Must Include:

• Name of preparation
• Complete list of ingredients (with quantities)
• Detailed compounding instructions (step-by-step)
• Equipment needed
• Quality control procedures
• Beyond-use date assignment criteria
• Storage requirements
• Packaging and labeling instructions
• Reference sources (if applicable)

Purpose:

• Ensures consistency batch to batch
• Provides complete instructions
• Training tool for personnel
• Reproducibility
• Quality assurance

Compounding Record (What Actually Happened):

Must Document:

• Formulation reference (which master formula used)
• Date and time of compounding
• Identity of compounder
• Ingredient lot numbers used
• Actual quantities measured
• Equipment used
• Quality control checks performed
• Beyond-use date assigned
• Pharmacist verification
• Any deviations from master formula

Purpose:

• Complete traceability
• Identify source if problems occur
• Demonstrates compliance
• Quality documentation
• Legal protection

Beyond-Use Dating

Definition: The date after which a compounded preparation should not be used

Not Same as Expiration Date:

• Commercial products: Extensive stability testing → Expiration date
• Compounded products: Limited or no testing → Conservative beyond-use date
• BUD always shorter than commercial equivalent
• Safety-focused approach

Factors Affecting BUD:

• Formulation type (aqueous vs. non-aqueous)
• Packaging (light-protective, moisture-protective)
• Storage conditions (refrigerated vs. room temperature)
• Ingredient stability
• Preservatives used (if any)
• Container type

Standard BUD Guidelines (Absent Stability Data):

Non-Aqueous Formulations (Oils, Ointments):

• Room temperature: Up to 90 days
• Refrigerated: Up to 180 days
• More stable (no water to support microbial growth)

Water-Containing Formulations (Creams, Solutions, Suspensions):

• Room temperature: Up to 14 days
• Refrigerated: Up to 30 days
• Higher risk (water supports microbes)
• Preservatives may extend (if validated)

Solid Dosage Forms (Capsules, Tablets):

• Room temperature: Up to 180 days
• Depends on ingredient stability
• Moisture-protective packaging important

Can Be Extended If:

• Published stability data supports
• Stability testing performed
• Validated methodology
• Documentation maintained

Conservative Approach Best:

• When in doubt, shorter BUD safer
• Patient safety paramount
• Reputation protection

Formulation Compounding Center’s BUD Practices:

• Conservative dating (safety first)
• Based on formulation type and published data
• Clearly labeled on every preparation
• Patient education on proper storage
• Won’t extend without supporting data

Quality Control Procedures

Verification Steps:

Pre-Compounding:

• Verify prescription/formula accuracy
• Check ingredient identity (label vs. COA)
• Ensure proper quantities available
• Equipment clean and calibrated
• Workspace prepared

During Compounding:

• Follow master formula exactly
• Measure carefully (proper technique)
• Mix thoroughly (appropriate method and time)
• Observe appearance and consistency
• Note any issues or deviations

Post-Compounding:

• Visual inspection (appearance, uniformity, color)
• Weight or volume verification (is quantity correct?)
• pH testing (when appropriate for formulation)
• Packaging integrity check
• Proper labeling
• Pharmacist final verification (every preparation)

Documentation:

• All quality checks recorded
• Any issues noted and addressed
• Pharmacist sign-off required
• Retained for appropriate time (varies by state, typically 2-5 years)

---

USP Chapter 797: Sterile Compounding Standards (Critical)

Why USP 797 is Life-or-Death Important

Injectable Medications Bypass Natural Defenses:

• Skin protects against environmental microbes
• Gastrointestinal tract has protective mechanisms
• Respiratory system filters air
• Injectable medications go directly into bloodstream or tissues
• No opportunity to neutralize contaminants

Contamination Consequences:

• Bacterial infections: Cellulitis, abscess, sepsis, death
• Fungal infections: Systemic mycosis, meningitis, death
• Endotoxin reactions: High fever, shock, organ failure
• Chemical contamination: Tissue damage, allergic reactions

The 2012 Lesson:

• 753 people infected from contaminated steroid injections
• 64 deaths (mostly fungal meningitis)
• Hundreds with permanent neurological damage
• Lives destroyed by sterile compounding failures
• Demonstrates why USP 797 compliance is non-negotiable

Scope: What USP 797 Covers

All Sterile Preparations:

• Injectable medications (IV, IM, subcutaneous)
• Ophthalmic preparations (eye drops)
• Inhalation solutions (respiratory medications)
• Irrigation solutions
• Implants
• Any preparation requiring sterility

Critical Difference from USP 795:

• Much more stringent requirements
• Expensive facilities (cleanrooms)
• Extensive personnel training
• Environmental monitoring
• Product testing
• Conservative beyond-use dates

Environmental Requirements (Cleanrooms)

ISO Classifications Defined:

• ISO = International Organization for Standardization
• Classification based on particle counts per cubic meter
• Lower number = cleaner (fewer particles)
• HEPA filtration achieves cleanliness

ISO Class 5 (Primary Engineering Control – PEC):

What It Is:

• Laminar Airflow Workbench (LAFW), Biological Safety Cabinet (BSC), or Compounding Aseptic Isolator (CAI)
• Where the actual sterile compounding occurs
• HEPA-filtered air: 99.97% efficiency at 0.3 microns
• Unidirectional airflow (all air flows same direction)
• Critical area protected from contamination

Particle Limits:

• Maximum 3,520 particles ≥0.5 microns per cubic meter
• Essentially particle-free
• Maintained continuously during compounding

Certification:

• Must be certified every 6 months minimum
• After any maintenance or repair
• If relocated
• Documented certification reports

ISO Class 7 (Buffer Room):

What It Is:

• Room surrounding the ISO Class 5 device
• Where supplies are staged and prepared
• HEPA-filtered air supply
• Positive pressure relative to ante-room (air flows out, not in)
• Controlled access (only qualified personnel)

Particle Limits:

• Maximum 352,000 particles ≥0.5 microns per cubic meter
• Still very clean
• Supports ISO Class 5 environment

Requirements:

• Non-shedding, easily cleanable surfaces
• No cardboard or unnecessary materials
• Supplies decontaminated before entry
• Personnel properly garbed
• Regular cleaning and disinfection

ISO Class 8 (Ante-Room):

What It Is:

• Transition area before entering buffer room
• Where personnel perform hand hygiene and garbing
• HEPA-filtered air
• Positive pressure relative to outside areas
• First line of contamination control

Particle Limits:

• Maximum 3,520,000 particles ≥0.5 microns per cubic meter
• Cleaner than normal room but not as clean as buffer room

Requirements:

• Hand washing facilities (sink with hot and cold water)
• Garbing supplies (gowns, masks, hair covers, shoe covers, gloves)
• Storage for personal items (removed before entry)
• Demarcation showing transition to controlled area

Air Handling Systems:

Critical Elements:

• HEPA filters throughout (buffer room and ante-room minimum)
• Pressure differentials maintained (most clean to least clean)
• Sufficient air changes per hour:
  • ISO Class 5: Continuous unidirectional flow
  • ISO Class 7: Minimum 30 air changes/hour
  • ISO Class 8: Minimum 20 air changes/hour
• Temperature control (typically 20-24°C)
• Humidity control (typically 30-60% relative humidity)
• Backup systems for critical areas
• Alarm systems for failures

Regular Certification:

• Every 6 months minimum
• Particle counts verified
• Airflow patterns tested
• Pressure differentials confirmed
• Documentation maintained

Formulation Compounding Center’s Cleanrooms:

• Complete ISO 5, 7, 8 infrastructure
• Multiple laminar flow hoods (redundancy)
• Certified air handling systems (tested semi-annually)
• Backup power for critical systems
• Alarm monitoring 24/7
• Exceeds minimum requirements

Personnel Requirements (Most Stringent)

Initial Training Requirements:

Didactic (Theory):

• Microbiology basics (microbes, contamination routes)
• Aseptic technique principles
• Hand hygiene importance and proper methods
• Garbing procedures (order, importance)
• Cleanroom behavior (what to do, what not to do)
• Cleaning and disinfection procedures
• USP 797 requirements overview
• Contamination risk factors
• Product testing understanding

Hands-On:

• Proper hand washing and antiseptic technique
• Correct garbing order and technique
• Aseptic manipulations (vial entry, ampule opening, etc.)
• Proper use of laminar flow hood
• Cleaning and disinfection practice
• Emergency procedures

Competency Assessment (Must Pass Before Independent Compounding):

Media Fill Testing:

• Most critical competency test
• Simulate actual sterile preparation using microbial growth medium (tryptic soy broth)
• Perform representative manipulations (vial entry, syringe manipulations, filtration, etc.)
• Incubate prepared media at body temperature for 14 days
• Observe daily for microbial growth (cloudiness)
• Pass: No growth observed = sterile technique adequate
• Fail: Any growth = contamination occurred, technique inadequate, retrain and retest

Frequency:

• Initial: Before any independent compounding
• Low/Medium Risk: Annually
• High Risk: Semi-annually
• After breaks in practice (extended leave)
• After retraining due to failed media fill

Glove Fingertip Testing:

• During or after compounding session
• Touch agar plates with gloved fingertips
• Incubate and check for growth
• Verifies proper technique maintained throughout compounding
• Part of ongoing competency assessment

Re-qualification:

• Annual assessment minimum (low/medium risk)
• Semi-annual for high risk
• After any failed assessment
• After significant procedure changes
• Ongoing training and evaluation

Garbing Requirements (Specific Order):

Proper Garbing Sequence (Inside to Outside):

1. Remove personal items (jewelry, watches, etc.)
2. Don shoe covers
3. Don hair/beard covers (cover all hair)
4. Don face mask (cover nose and mouth)
5. Perform hand hygiene (antiseptic hand wash)
6. Don non-shedding gown (sterile for high-risk)
7. Enter ISO Class 7 (buffer room)
8. Perform antiseptic hand hygiene again
9. Don sterile gloves
10. Sanitize gloved hands with sterile 70% isopropyl alcohol

Garb Requirements:

• Low-lint or lint-free materials
• Covers all skin, hair
• No cosmetics, perfumes, or jewelry in compounding area
• No artificial nails (harbor bacteria, interfere with gloves)
• Dedicated garb (not worn outside controlled areas)

Re-garbing:

• When leaving and re-entering controlled area
• If garb torn or contaminated
• After extended time (shift change)

Environmental Monitoring

Purpose: Verify cleanroom actually clean and personnel technique maintaining sterility

Air Sampling:

Viable Air Sampling (Microbial):

• Air samples collected onto agar plates
• Incubated to grow any microbes present
• Quantifies bioburden (microbial load) in air
• Frequency: At least monthly, more often initially

Non-Viable Particle Counting:

• Electronic particle counter measures particles
• Verifies ISO classification maintained
• Real-time monitoring possible
• During certification (every 6 months)

Action Levels:

• Defined microbial limits for each ISO class
• Exceeding limit triggers investigation and corrective action
• Trending identifies problems before failures

Surface Sampling:

What’s Sampled:

• Work surfaces in ISO Class 5
• Equipment surfaces
• Walls, floors, ceilings in buffer room
• High-touch areas

Method:

• Contact plates or swabs
• Transferred to growth media
• Incubated and counted
• Frequency: Regular schedule based on risk

Action If Contamination Found:

• Immediate cleaning and disinfection
• Re-sampling to verify effectiveness
• Investigation of source
• Corrective action (retraining, procedure changes)
• Documentation

Personnel Monitoring:

Glove Fingertip Testing:

• At end of compounding session
• Touch agar plates with gloved fingertips
• Incubate and check for growth
• Verifies aseptic technique maintained
• Regular frequency (every compounding session or sample)

Gown Sampling (Periodic):

• Touch plates to gown surface
• Assesses gown cleanliness and shedding
• Verifies garbing effectiveness

Formulation Compounding Center’s Monitoring:

• Comprehensive environmental monitoring program
• Air sampling monthly (viable and non-viable)
• Surface sampling regular schedule
• Glove fingertip testing every session
• Trending and documentation
• Immediate investigation of any excursions
• Zero tolerance for failures

Product Testing

Sterility Testing:

Purpose: Verify finished preparation actually sterile

Method (USP <71> Sterility Tests):

• Sample of prepared product transferred to growth media
• Incubated for 14 days at optimal temperature
• Observed daily for microbial growth
• No growth = sterile
• Any growth = contamination, product cannot be used

When Required:

• High-risk preparations (mandated by USP 797)
• New formulations (validation)
• After facility issues or personnel problems
• Periodically for ongoing verification

Endotoxin Testing:

Purpose: Detect bacterial endotoxins (pyrogens)

What Are Endotoxins:

• Components of bacterial cell walls
• Cause severe fever reactions (pyrogen = fever-causing)
• Can cause shock, organ failure
• Not destroyed by sterilization (bacteria dead but endotoxin remains)
• Must prevent contamination, not rely on sterilization

Method (LAL Test – Limulus Amebocyte Lysate):

• Sample mixed with LAL reagent (from horseshoe crab blood)
• Endotoxin causes gel formation or color change
• Quantitative results (endotoxin units)
• Limits defined by USP

When Required:

• Large-volume parenterals (IV solutions)
• High-risk preparations
• When endotoxin contamination risk present

Potency Testing:

Purpose: Verify preparation contains stated amount of active ingredient

Methods:

• High-Performance Liquid Chromatography (HPLC) – most common
• Other analytical methods as appropriate
• Compares to standard of known concentration

When Performed:

• Critical formulations (new, complex)
• High-risk or high-value preparations
• Verification of compounding accuracy
• Investigation of suspected problems

Formulation Compounding Center’s Testing:

• Sterility testing for high-risk preparations
• Endotoxin testing when appropriate
• Potency verification for critical formulations
• Comprehensive quality control
• Documentation of all testing
• Products released only after verification

Beyond-Use Dating (Conservative for Sterility)

Risk Levels and BUD:

Immediate Use (Highest Risk):

• Compounded and administered within 1 hour
• Emergency situations only
• No storage
• Used immediately at point of care

Low Risk:

• Simple manipulations in ISO Class 5
• Single-vial preparations, simple reconstitutions
• BUD: 48 hours at room temperature, 14 days refrigerated

Medium Risk:

• Multiple ingredients or transfers
• Longer compounding time
• BUD: 30 hours at room temperature, 9 days refrigerated

High Risk:

• Non-sterile ingredients used
• Compounded outside ISO Class 5 temporarily
• Longest compounding time
• BUD: 24 hours at room temperature, 3 days refrigerated (only if sterility tested)

Why So Conservative:

• Sterility cannot be assumed, only verified
• Shorter dates = lower risk
• Safety margin for patients
• Accounts for unknowns

---

USP Chapter 800: Hazardous Drug Handling

Purpose and Scope

Protecting Personnel and Environment:

• Some medications hazardous to those handling them
• Reproductive risks (teratogenic, fertility effects)
• Carcinogenic potential
• Organ toxicity with exposure
• Personnel protection essential

What Qualifies as Hazardous:

• NIOSH List of Hazardous Drugs (regularly updated)
• Many chemotherapy agents
• Some hormones (testosterone, estrogens at certain concentrations)
• Immunosuppressants
• Some antivirals
• Other medications with reproductive/carcinogenic risks

Applies Throughout Drug Lifecycle:

• Receiving and unpacking
• Storage
• Compounding and preparation
• Dispensing
• Administration
• Waste disposal
• Spill cleanup

Containment Strategies

Engineering Controls:

Biological Safety Cabinets (BSC):

• Negative pressure (air pulled into cabinet)
• HEPA filtration of exhaust
• Protects personnel and environment
• Required for most hazardous compounding

Containment Isolators:

• Completely enclosed compounding environment
• Arm ports for manipulation
• HEPA-filtered
• Ultimate protection

Closed-System Drug Transfer Devices (CSTD):

• Prevent exposure during drug transfers
• Sealed system
• Reduces contamination risk

Negative Pressure Rooms:

• For hazardous drug compounding areas
• Air flows in, not out
• Exhausted to outside (not recirculated)
• Protects personnel outside room

Administrative Controls:

Policies and Procedures:

• Written procedures for all hazardous drug activities
• Training programs
• Spill management protocols
• Emergency procedures
• Designated hazardous drug areas

Access Restrictions:

• Only trained personnel
• Limited access to compounding areas
• Signage designating hazardous areas

Personal Protective Equipment (PPE):

Required PPE:

• Double gloving (chemotherapy-tested gloves)
• Protective gowns (lint-free, impermeable)
• Respiratory protection (when risk of aerosol)
• Eye/face protection (goggles or face shield)
• Sleeve covers (if gown sleeves not adequate)

Proper Use:

• Don before handling hazardous drugs
• Change gloves every 30 minutes or if torn
• Remove carefully (avoid contamination)
• Dispose as hazardous waste

Environmental Monitoring

Surface Wipe Sampling:

• Collect samples from work surfaces, floors, equipment
• Analyze for drug residues
• Detects contamination
• Verifies cleaning effectiveness

Frequency:

• Initially (establish baseline)
• Every 6 months minimum
• After changes in procedures
• When contamination suspected

Action if Contamination Found:

• Enhanced cleaning and disinfection
• Re-evaluation of procedures
• Personnel retraining
• Protective equipment assessment
• Re-sampling to verify correction

Waste Disposal

Segregation:

• Hazardous drug waste separate from regular waste
• Clearly marked containers (yellow bins typically)
• Different disposal requirements

Handling:

• Use proper containers (leak-proof, puncture-resistant)
• Close securely when full (do not overfill)
• Minimize exposure during disposal
• PPE required when handling waste

Disposal:

• Contract with hazardous waste disposal company
• EPA-compliant disposal methods
• Incineration typically
• Documentation of disposal (manifests)
• Regular pickup schedule

Spill Management

Spill Kits:

• Available in all hazardous drug areas
• Contents: absorbent pads, gown, gloves, goggles, disposal bags, warning signs
• Regularly inspected (ensure complete)

Spill Response:

1. Contain spill (absorbent materials)
2. Don proper PPE
3. Clean up using appropriate technique (outside to inside)
4. Place all materials in hazardous waste
5. Clean area thoroughly
6. Document incident
7. Investigate cause
8. Corrective action

Reporting:

• Internal reporting to safety officer
• Investigation of cause
• Prevention strategies
• Training reinforcement

Formulation Compounding Center’s USP 800 Compliance:

• Designated hazardous drug compounding areas (negative pressure)
• Biological safety cabinets for hazardous compounding
• Complete PPE protocols (enforced)
• Environmental monitoring program (surface wipe sampling)
• Hazardous waste disposal contracted (EPA-compliant)
• Spill kits placed strategically
• Comprehensive personnel training
• Regular audits and updates

---

Why Full USP Compliance Matters

Patient Safety (Primary Reason)

USP 795 Protects By:

• Ensuring pharmaceutical-grade ingredients (known purity, potency)
• Proper equipment and techniques (accurate dosing)
• Documentation (traceability if problems)
• Quality control (consistency and accuracy)

USP 797 Prevents:

• Infections from contaminated injectables
• Sepsis and death from bacterial contamination
• Fungal meningitis from mold contamination
• Endotoxin reactions from bacterial toxins
• Catastrophic outcomes from sterility failures

USP 800 Protects:

• Personnel from hazardous drug exposure
• Environment from contamination
• Reproductive health of staff
• Long-term health (cancer prevention)

Legal and Regulatory Requirements

State Board Compliance:

• State pharmacy laws reference USP standards
• Failure = violation of pharmacy law
• License suspension or revocation possible
• Fines and penalties
• Mandatory corrective action

FDA Expectations:

• FDA inspections assess USP compliance
• Warning letters cite USP violations
• Can recommend state action
• Pattern of violations = federal enforcement

Professional Liability:

• Standard of care includes USP compliance
• Malpractice claims if patient harmed
• Prescriber liability if partner with non-compliant pharmacy
• “Knew or should have known” about quality failures

Professional Reputation

Builds Trust:

• Prescribers confident in quality
• Patients trust pharmaceutical-grade products
• Competitive advantage
• Industry respect

Differentiates Quality:

• Separates legitimate operations from amateur compounders
• Demonstrates commitment to safety over profit
• Attracts quality-conscious providers and patients

---

Verifying USP Compliance

What to Ask

Questions for Compounding Pharmacies:

USP 795 (Non-Sterile):

• “Are you USP 795 compliant?”
• “Where do you source ingredients?” (Should say: pharmaceutical-grade, FDA-registered suppliers)
• “Can you provide Certificates of Analysis?” (Should readily provide)
• “What quality control do you perform?” (Should describe procedures)

USP 797 (Sterile – Critical):

• “Are you USP 797 certified?” (Should be immediate yes if selling injectables)
• “Do you have ISO Class 5, 7, 8 cleanrooms?” (Required)
• “Can I see photos of your sterile compounding facility?” (Legitimate pharmacies show readily)
• “How often are your cleanrooms certified?” (Should say: every 6 months)
• “What sterility testing do you perform?” (Should describe program)
• “How do you train and validate personnel?” (Should mention media fills)

USP 800 (Hazardous Drugs):

• “Are you USP 800 compliant?” (If handling hazardous drugs)
• “What containment equipment do you use?” (BSCs, negative pressure rooms)
• “What PPE do your staff use?” (Double gloves, gowns, etc.)
• “How do you dispose of hazardous waste?” (Contracted EPA-compliant disposal)

Red Flags

Evasive Answers:

• “We follow USP guidelines” (not same as compliant)
• “That’s proprietary information” (Standards aren’t proprietary)
• “You don’t need to worry about that” (You absolutely do)
• Defensive or irritated responses (Legitimate operations welcome questions)

Cannot Provide Documentation:

• No certificates of analysis
• No cleanroom certification reports
• No environmental monitoring data
• Vague about facilities

Selling Injectables Without Cleanrooms:

• Claims to compound sterile products
• But has no ISO-classified cleanroom
• Extremely dangerous
• Immediate disqualification

Formulation Compounding Center’s Transparency

Complete Compliance Documented:

• USP 795, 797, 800 all certified
• Documentation available upon request
• Cleanroom certification reports current
• Environmental monitoring data maintained
• All questions answered directly
• Facility information shared openly
• Nothing to hide, everything to verify

Welcomes Verification:

• Encourages questions from providers and patients
• Proud of standards maintained
• Transparent about all processes
• Competitive advantage through quality

---

Conclusion: USP Standards Protect Lives

USP 795, 797, and 800 represent the pharmaceutical industry’s distilled wisdom on safe compounding practices. These standards exist because people died when they weren’t followed. Compliance isn’t optional, isn’t negotiable, and isn’t something to compromise on for cost savings.

Key Takeaways:

✓ USP 795 ensures non-sterile compounding quality through pharmaceutical-grade ingredients, proper equipment, documentation, and quality control

✓ USP 797 prevents infections and deaths from contaminated injectables through cleanrooms, personnel training, environmental monitoring, and testing

✓ USP 800 protects personnel and environment from hazardous drug exposure through containment, PPE, monitoring, and safe disposal

✓ Compliance is legally required – state pharmacy laws and FDA expectations reference USP standards

✓ Verification is straightforward – ask direct questions, request documentation, check credentials

✓ Formulation Compounding Center exemplifies complete compliance across all three standards with documented, verifiable quality

For Healthcare Providers:

• Only partner with USP-compliant compounding pharmacies
• Verify compliance (don’t assume)
• Your professional liability extends to compounding partner quality
• Patient safety depends on pharmaceutical-grade standards

For Patients:

• Your medications should come from USP-compliant pharmacies
• Ask questions about quality standards
• Verify cleanrooms exist if receiving injectable medications
• Don’t accept “research chemicals” or non-pharmaceutical sources

Newtropin’s Commitment:

• Partnership only with fully compliant 503A pharmacy
• Complete USP 795, 797, 800 certification
• Pharmaceutical-grade quality throughout
• Transparent verification welcome
• Patient safety absolute priority

The difference between USP-compliant and non-compliant compounding is the difference between pharmaceutical-grade medications and potentially dangerous preparations. Choose wisely. Verify completely. Never compromise.